Vacation Alert -

Markets reverse yesterday's gain. More drops ahead, watch to see potential support levels.

PPI breaths life into the markets. Are we out of the woods yet? Probably not - here's why!

Oracle using Financial leverage of $100 B debt. Here is what we think!

Higher for longer: Find out where to invest while rates remain elevated.

What should you do with NVIDIA?

Verve: Is there an opportunity to profit from Verve in short term?

Exploring Bond ETFs. Can this be a good strategy for capital gains when Fed cuts interest rate?

Health Canada Priority Review for Casgevy from CRISPR Therapeutics. Will this move the needle?

Can AI deliver greater EPS within 12 months and seed the next bull market? lets find out!

Stocks raise despite jump in yields!!

I think Meta & Amazon Will thrive Despite Market Turbulence | Could be the last 2 of Mag 7 standing?

Oracle and Palantir Partnership: Revolutionizing Cloud and AI Solutions | Tech News Update

Benign ISM PMI boosts markets. Rate cut hopes muted. Intel drops 8% on losses in foundry division.

Here's how investors get burned.

Key indices fall below support line of bull channel. Oil firms up. Is the party over?

Verve Therapeutics' BREAKING: Clinical Trial Halted After Adverse Events | Biotech News Update

Is it time to buy ILMN? What is their status in AI adoption?

Battle of Titans: Nvidia vs. Intel vs. AMD in the AI Chip Market

CRISPR Therapeutics: Is it time to buy? Why is the stock falling?

Altimmune Stock: NASH Hopeful with Weight Loss Potential (2024)

Unveiling Palantir: A First Look at the AI Data Giant -comparing with NVDA

EP 5: Moving averages. Technical Analysis for beginners full course - 10 Mins per day .

Supermicro (SMCI): From Humble Beginnings to Tech Powerhouse (Innovation, Efficiency, US-Made)

All indices end in the Red. I still feel we are just consolidating.

Jeff Galvin talks to us about AGT 103-T updates as well as Addimmune.

BlueBird Bio to restate accounts. Revenue jump is overshadowed by lack of financial controls.

Key indices fall below support line of bull channel. Are we due for a trend reversal?

Revolutionizing Drug Discovery with BioNeMo: Exploring Nvidia's AI Platform

Things are getting better for Illumina, all at once - find out more!